Literature DB >> 16505651

A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.

David Fraenkel1, Claire Rickard, Peter Thomas, Joan Faoagali, Narelle George, Robert Ware.   

Abstract

OBJECTIVE: Central venous catheters are the predominant cause of nosocomial bacteremia; however, the effectiveness of different antimicrobial central venous catheters remains uncertain. We compared the infection rate of silver-platinum-carbon (SPC)-impregnated catheters with rifampicin-minocycline (RM)-coated catheters.
DESIGN: A large, single-center, prospective randomized study.
SETTING: Twenty-two-bed adult general intensive care unit in a large tertiary metropolitan hospital in Brisbane, Australia (2000-2001). PATIENTS: Consecutive series of all central venous catheterizations in intensive care unit patients.
INTERVENTIONS: Randomization, concealment, and blinding were carefully performed. Catheter insertion and care were performed according to published guidelines. Blood cultures were taken at central venous catheter removal, and catheter-tip cultures were performed by both roll-plate and sonication techniques. Pulsed field gel electrophoresis was used to establish shared clonal origin for matched isolates.
MEASUREMENTS AND MAIN RESULTS: Central venous catheter colonization and catheter-related bloodstream infection were determined with a blinded technique using the evaluation of the extensive microbiological and clinical data collected and a rigorous classification system. Six hundred forty-six central venous catheters (RM 319, SPC 327) were inserted, and 574 (89%) were microbiologically evaluable. Colonization rates were lower for the RM catheters than SPC catheters (25 of 280, 8.9%; 43 of 294, 14.6%; p=.039). A Kaplan-Meier analysis that included catheter time in situ did not quite achieve statistical significance (p=.055). Catheter-related bloodstream infection was infrequent for both catheter-types (RM 4, 1.4%; SPC 5, 1.7%).
CONCLUSIONS: The SPC catheter is a clinically effective antimicrobial catheter; however, the RM catheter had a lower colonization rate. Both catheter types had low rates of catheter-related bloodstream infection. These results indicate that future studies will require similar rigorous methodology and thousands of central venous catheters to demonstrate differences in catheter-related bloodstream infection rates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16505651     DOI: 10.1097/01.CCM.0000201404.05523.34

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  19 in total

1.  Health technology assessment in critical care.

Authors:  Damon C Scales; Andreas Laupacis
Journal:  Intensive Care Med       Date:  2007-10-20       Impact factor: 17.440

Review 2.  Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials.

Authors:  B S Niël-Weise; T Stijnen; P J van den Broek
Journal:  Intensive Care Med       Date:  2007-10-17       Impact factor: 17.440

3.  In vitro efficacy of a novel active-release antimicrobial coating to eradicate biofilms of Pseudomonas aeruginosa.

Authors:  Dustin L Williams; Julia M Lerdahl; Bryan S Haymond; Roy D Bloebaum
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

4.  In vivo biocompatibility and in vitro efficacy of antimicrobial gendine-coated central catheters.

Authors:  Mohamed A Jamal; Ray Y Hachem; Joel Rosenblatt; Mark J McArthur; Edd Felix; Ying Jiang; Ramesh C Tailor; Issam Raad
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

5.  Assessment of the Potential for Inducing Resistance in Multidrug-Resistant Organisms from Exposure to Minocycline, Rifampin, and Chlorhexidine Used To Treat Intravascular Devices.

Authors:  Joel Rosenblatt; Nylev Vargas-Cruz; Ruth A Reitzel; Issam I Raad
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

6.  In vitro activity and durability of a combination of an antibiofilm and an antibiotic against vascular catheter colonization.

Authors:  Mohammad D Mansouri; Richard A Hull; Charles E Stager; Richard M Cadle; Rabih O Darouiche
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

7.  Prevention of biofilm colonization by Gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine.

Authors:  Mohamed A Jamal; Joel S Rosenblatt; Ray Y Hachem; Jiang Ying; Egbert Pravinkumar; Joseph L Nates; Anne-Marie P Chaftari; Issam I Raad
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

8.  In vivo efficacy of a silicone‒cationic steroid antimicrobial coating to prevent implant-related infection.

Authors:  Dustin L Williams; Bryan S Haymond; James P Beck; Paul B Savage; Vinod Chaudhary; Richard T Epperson; Brooke Kawaguchi; Roy D Bloebaum
Journal:  Biomaterials       Date:  2012-08-30       Impact factor: 12.479

Review 9.  Access technique and its problems in parenteral nutrition - Guidelines on Parenteral Nutrition, Chapter 9.

Authors:  K W Jauch; W Schregel; Z Stanga; S C Bischoff; P Brass; W Hartl; S Muehlebach; E Pscheidl; P Thul; O Volk
Journal:  Ger Med Sci       Date:  2009-11-18

Review 10.  Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.

Authors:  Nai Ming Lai; Nathorn Chaiyakunapruk; Nai An Lai; Elizabeth O'Riordan; Wilson Shu Cheng Pau; Sanjay Saint
Journal:  Cochrane Database Syst Rev       Date:  2016-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.